Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/16 → 10/31/16 |
Funding
- Medpace Inc: $8,600.00
16MULTI-16-HI (HALO-107-101) A Phase 1b Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined with Pembrolizumab in Subjects with Selected Hayluronan-High Solid Tumors
- Arnold, Susanne (PI)